The purpose of this study was to explore the clinical and laboratory risk factors for the progression of CAEBV infection to HLH, which is extremely significant for enabling clinicians to adjust their treatment choices in a timely manner, thus prolonging the survival time and improving the prognosis of CAEBV-infected patients.
← all excerpts
Development of a Nomogram to Predict the Risk of Chronic Active Epstein-Barr Virus Infection Progressing to Hemophagocytic Lymphohistiocytosis.
1
—
—